Home Medicine Laboratory approaches for predicting and managing the risk of cardiovascular disease: postanalytical opportunities of lipid and lipoprotein testing
Article Publicly Available

Laboratory approaches for predicting and managing the risk of cardiovascular disease: postanalytical opportunities of lipid and lipoprotein testing

  • Michel R. Langlois

    Dr. Michel Langlois, born October 13, 1967 studied Medicine at the University of Ghent, Belgium and specialized in Laboratory Medicine with emphasis on clinical chemistry and cardiovascular diagnostics. He presented his PhD thesis on the haptoglobin polymorphism in 1997, followed by his postdoctoral research on iron metabolism and oxidative stress in 1998 – 2001. Since 2001, he continued his activities in clinical chemistry and lipidology at AZ St-Jan hospital, Bruges, combined with a position of Professor at Ghent University (since 2009). Prof. Langlois is current President of the Royal Belgian Society of Clinical Chemistry (RBSCC), Vice-President of the Belgian Lipid Club (Belgian Atherosclerosis Society), and member of the European Federation of Clinical Chemistry and Laboratory Medicine (EFCC) Working Groups “Cardiac Markers” and “Guidelines”. For his research in risk biomarkers of atherosclerosis he received 9 scientifi c awards. Prof. Langlois is Editorial Board member of the journal Clinica Chimica Acta and a scientifi c reviewer for many other international journals including CCLM.

    EMAIL logo
Published/Copyright: April 10, 2012

Received: 2011-09-10
Accepted: 2012-03-19
Published Online: 2012-04-10
Published in Print: 2012-07-01

©2012 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Masthead
  2. Masthead
  3. Editorial
  4. Fit for Future – Help Healing the World: IFCC-WorldLab in Berlin 2011
  5. Reviews
  6. European medical laboratory accreditation. Present situation and steps to harmonisation
  7. Quality assurance and quality control in the routine molecular diagnostic laboratory for infectious diseases
  8. Translating exome sequencing from research to clinical diagnostics
  9. Laboratory approaches for predicting and managing the risk of cardiovascular disease: postanalytical opportunities of lipid and lipoprotein testing
  10. Pregnancy-associated plasma protein A: spotlight on kidney diseases
  11. Measurement of factor XIII activity in plasma
  12. Update on multiple sclerosis, its diagnosis and treatments
  13. Recommendations on prenatal screening and the connections to other diseases such as thyroid dysfunction
  14. Mini Reviews
  15. Experience of Médecins Sans Frontières in laboratory medicine in resource-limited settings
  16. Highlights in inflammatory bowel disease – from bench to bedside
  17. Opinion Papers
  18. Implementation of standardization in clinical practice: not always an easy task
  19. IFCC standardised HbA1c: should the world be as one?
  20. Reflective testing: adding value to laboratory testing
  21. Original Articles
  22. Low angle light scattering analysis: a novel quantitative method for functional characterization of human and murine platelet receptors
  23. The recoveryELISA – a newly developed immunoassay for measurement of therapeutic antibodies and the target antigen during antibody therapy
  24. Implementation of new recommendations for the diagnosis of gestational diabetes: a 5-month audit
  25. Exploring synergies between academia and vaccine manufacturers: a pilot study on how to rapidly produce vaccines to combat emerging pathogens
Downloaded on 16.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2011-0636/html
Scroll to top button